BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15571716)

  • 1. Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity.
    Henrich S; Lindberg I; Bode W; Than ME
    J Mol Biol; 2005 Jan; 345(2):211-27. PubMed ID: 15571716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and function of eukaryotic proprotein processing enzymes of the subtilisin family of serine proteases.
    Van de Ven WJ; Roebroek AJ; Van Duijnhoven HL
    Crit Rev Oncog; 1993; 4(2):115-36. PubMed ID: 8420571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the binding pockets of mammalian proprotein convertases and its implications for the design of specific small molecule inhibitors.
    Tian S; Jianhua W
    Int J Biol Sci; 2010 Feb; 6(1):89-95. PubMed ID: 20151049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions.
    Seidah NG; Chrétien M; Day R
    Biochimie; 1994; 76(3-4):197-209. PubMed ID: 7819324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proprotein convertases furin and PACE4 play a significant role in tumor progression.
    Bassi DE; Mahloogi H; Klein-Szanto AJ
    Mol Carcinog; 2000 Jun; 28(2):63-9. PubMed ID: 10900462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cDNA structure of the mouse and rat subtilisin/kexin-like PC5: a candidate proprotein convertase expressed in endocrine and nonendocrine cells.
    Lusson J; Vieau D; Hamelin J; Day R; Chrétien M; Seidah NG
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6691-5. PubMed ID: 8341687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proprotein convertases, 20 years later.
    Seidah NG
    Methods Mol Biol; 2011; 768():23-57. PubMed ID: 21805237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knock-out mouse models of proprotein convertases: unique functions or redundancy?
    Creemers JW; Khatib AM
    Front Biosci; 2008 May; 13():4960-71. PubMed ID: 18508561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proprotein convertases and their implication in sterol and/or lipid metabolism.
    Seidah NG; Khatib AM; Prat A
    Biol Chem; 2006 Jul; 387(7):871-7. PubMed ID: 16913836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kindest cuts of all: crystal structures of Kex2 and furin reveal secrets of precursor processing.
    Rockwell NC; Thorner JW
    Trends Biochem Sci; 2004 Feb; 29(2):80-7. PubMed ID: 15102434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The crystal structure of the proprotein processing proteinase furin explains its stringent specificity.
    Henrich S; Cameron A; Bourenkov GP; Kiefersauer R; Huber R; Lindberg I; Bode W; Than ME
    Nat Struct Biol; 2003 Jul; 10(7):520-6. PubMed ID: 12794637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7.
    Lissitzky JC; Luis J; Munzer JS; Benjannet S; Parat F; Chrétien M; Marvaldi J; Seidah NG
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):133-8. PubMed ID: 10657249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate cleavage analysis of furin and related proprotein convertases. A comparative study.
    Remacle AG; Shiryaev SA; Oh ES; Cieplak P; Srinivasan A; Wei G; Liddington RC; Ratnikov BI; Parent A; Desjardins R; Day R; Smith JW; Lebl M; Strongin AY
    J Biol Chem; 2008 Jul; 283(30):20897-906. PubMed ID: 18505722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for differences in substrate selectivity in Kex2 and furin protein convertases.
    Holyoak T; Kettner CA; Petsko GA; Fuller RS; Ringe D
    Biochemistry; 2004 Mar; 43(9):2412-21. PubMed ID: 14992578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The self-inhibited structure of full-length PCSK9 at 1.9 A reveals structural homology with resistin within the C-terminal domain.
    Hampton EN; Knuth MW; Li J; Harris JL; Lesley SA; Spraggon G
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14604-9. PubMed ID: 17804797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histidine-rich human salivary peptides are inhibitors of proprotein convertases furin and PC7 but act as substrates for PC1.
    Basak A; Ernst B; Brewer D; Seidah NG; Munzer JS; Lazure C; Lajoie GA
    J Pept Res; 1997 Jun; 49(6):596-603. PubMed ID: 9266488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activation and physiological functions of the proprotein convertases.
    Seidah NG; Mayer G; Zaid A; Rousselet E; Nassoury N; Poirier S; Essalmani R; Prat A
    Int J Biochem Cell Biol; 2008; 40(6-7):1111-25. PubMed ID: 18343183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proprotein convertases: lessons from knockouts.
    Scamuffa N; Calvo F; Chrétien M; Seidah NG; Khatib AM
    FASEB J; 2006 Oct; 20(12):1954-63. PubMed ID: 17012247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proprotein convertases regulate trafficking and maturation of key proteins within the secretory pathway.
    Cendron L; Rothenberger S; Cassari L; Dettin M; Pasquato A
    Adv Protein Chem Struct Biol; 2023; 133():1-54. PubMed ID: 36707198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proprotein convertases are potential targets in the treatment of dyslipidemia.
    Seidah NG; Prat A
    J Mol Med (Berl); 2007 Jul; 85(7):685-96. PubMed ID: 17351764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.